home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

15.73 +0.18 (+1.16%)

Streaming Delayed Price Updated: 10:43 AM EDT, Jul 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024

April 24, 2024

From Novocure

Via Business Wire

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

April 05, 2024

From Novocure

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

April 03, 2024

Via Benzinga

Novocure to Report First Quarter 2024 Financial Results

April 01, 2024

From Novocure

Via Business Wire

Why NovoCure Stock Soared 18.3% This Week ↗

March 30, 2024

Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.

Via The Motley Fool

Why Novocure Stock Is Jumping Today ↗

March 28, 2024

Novocure had good news mixed with some not-so-good news.

Via The Motley Fool

Peeling Back The Layers: Exploring NovoCure Through Analyst Insights ↗

March 27, 2024

Via Benzinga

Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows ↗

March 27, 2024

Novocure's Phase 3 METIS trial results: TTFields therapy, combined with supportive care, significantly prolongs time to intracranial progression for NSCLC brain metastases patients compared to...

Via Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗

March 27, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Via Benzinga

Topics Stocks

Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment ↗

March 27, 2024

The company uses electrical fields to interrupt the rampant cellular division characteristic of cancer.

Via Investor's Business Daily

NovoCure Ltd. (NASDAQ: NVCR) Leading the Way in Thursday Trading Based on Percentage Gain

January 18, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 27, 2024

Via Benzinga

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

March 27, 2024

From Novocure

Via Business Wire

INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO

March 11, 2024

From Novocure

Via Business Wire

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

NovoCure (NVCR) Q4 2023 Earnings Call Transcript ↗

February 22, 2024

NVCR earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

February 22, 2024

From Novocure

Via Business Wire

Earnings Scheduled For February 22, 2024 ↗

February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Via Benzinga

AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday? ↗

January 18, 2024

During midday Thursday trading in New York, U.S. stocks displayed mixed performance, with the technology sector outperforming others as investors maintained a bullish outlook on artificial...

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

Why Is Cancer Focused Novocure Stock Trading Higher Today? ↗

January 18, 2024

Novocure's TTFields therapy gains FDA acceptance for non-small cell lung cancer treatment after platinum-based therapy. PMA filing under FDA review. Decision expected in 2H 2024.

Via Benzinga

Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On Thursday ↗

January 18, 2024

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Fastenal Company (NASDAQ: FAST) rose during Thursday’s session after the company reported...

Via Benzinga

Topics Stocks

Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer

January 18, 2024

From Novocure

Via Business Wire

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday ↗

January 10, 2024

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.

Via Benzinga

Topics Stocks

Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma

January 09, 2024

From Novocure

Via Business Wire

Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update

January 08, 2024

From Novocure

Via Business Wire

Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer

January 04, 2024

From Novocure

Via Business Wire

Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

From Novocure

Via Business Wire

7 Nasdaq Stocks Down 59% Set to Soar at Least 141% ↗

December 12, 2023

Wall Street always think companies are high-growth potential stocks but a little circumspection is required before buying

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com